Description

n-[(2E)-5-(Methoxymethyl)-1,3,4-Thiadiazol-2(3H)-Ylidene]-1-(Propan-2-Yl)-1,5,6,7-Tetrahydrocyclopenta[B]Pyrazolo[4,3-E]Pyridine-4-Carboxamide is a sophisticated heterocyclic organic compound featuring a complex fused-ring structure, making it a valuable advanced pharmaceutical intermediate and research chemical. Its molecular architecture is specifically designed for high-affinity binding and targeted activity in medicinal chemistry applications. This compound is primarily utilized by pharmaceutical R&D teams and fine chemical manufacturers engaged in the development of novel therapeutic agents.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly for central nervous system (CNS) or oncology targets.
• Medicinal Chemistry Research: Used as a key scaffold or precursor in drug discovery programs for structure-activity relationship (SAR) studies and lead optimization.
• Biochemical Tool Compound: Employed in pharmacological research as a selective ligand or inhibitor to study specific biological pathways and receptor interactions.
• Fine Chemical Synthesis: Acts as a specialized intermediate for the custom synthesis of complex, high-value molecules for contract research organizations (CROs) and CDMOs.
• Reference Standard: Supplied as a high-purity analytical standard for quality control and method development in analytical laboratories.

Basic Information

Product Name	n-[(2E)-5-(Methoxymethyl)-1,3,4-Thiadiazol-2(3H)-Ylidene]-1-(Propan-2-Yl)-1,5,6,7-Tetrahydrocyclopenta[B]Pyrazolo[4,3-E]Pyridine-4-Carboxamide
CAS No.	1179478-14-8
Molecular Formula	C18H22N6O2S
Molecular Weight	386.47 g/mol
Synonyms	1-Isopropyl-1,5,6,7-tetrahydrocyclopenta[b]pyrazolo[4,3-e]pyridine-4-carboxylic acid (5-methoxymethyl-1,3,4-thiadiazol-2-ylidene)amide; (2E)-N-[5-(Methoxymethyl)-1,3,4-thiadiazol-2(3H)-ylidene]-1-(propan-2-yl)-1,5,6,7-tetrahydrocyclopenta[b]pyrazolo[4,3-e]pyridine-4-carboxamide; CPBPP-Carboxamide derivative; Thiadiazolylidene tetrahydrocyclopentapyrazolopyridine carboxamide
EINECS	Contact for details

Quality Control

Our production of n-[(2E)-5-(Methoxymethyl)-1,3,4-Thiadiazol-2(3H)-Ylidene]-1-(Propan-2-Yl)-1,5,6,7-Tetrahydrocyclopenta[B]Pyrazolo[4,3-E]Pyridine-4-Carboxamide adheres to stringent cGMP and ISO 9001 quality management standards. Every batch undergoes comprehensive analytical characterization using HPLC, NMR, and LC-MS to confirm identity, purity, and consistency. Certificates of Analysis (COA) with full analytical data are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound is light-sensitive; prolonged exposure to light should be avoided to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Single Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.